Marbofloxacin
Cat. No.：YN250917
| 产品名称: | Marbofloxacin |
| CAS No.: | 115550-35-1 |
| Chemical Name: | 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic acid |
| Synonyms: | 马波沙星 |
| 分子量: | 362.36 |
| 分子式: | C₁₇H₁₉FN₄O₄ |
| SMILES: | O=C(C(C1=O)=CN2N(C)COC3=C(N4CCN(C)CC4)C(F)=CC1=C32)O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Marbofloxacin 是第三代具有口服活性的氟喹诺酮类抗菌剂，具有广谱的杀菌活性和良好的疗效。 Marbofloxacin 可用于研究革兰氏阳性和革兰氏阴性细菌以及支原体引起的感染。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Ferran, A.A., Toutain, P.L., and Bousquet-Mélou, A.Impact of early versus later fluoroquinolone treatment on the clinical; microbiological and resistance outcomes in a mouse-lung model of Pasteurella multocida infectionVet. Microbiol.148(2-4),292-297(2011)
Spreng, M., Deleforge, J., Thomas, V., et al.Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolatesJ. Vet. Pharmacol. Ther.18(4),284-289(1995)
Lhermie, G., Ferran, A.A., Assié, S., et al.Impact of timing and dosage of a fluoroquinolone treatment on the microbiological, pathological, and clinical outcomes of calves challenged with Mannheimia haemolyticaFront. Microbiol.237(7),(2016)
Pineda, C., Aguilera-Tejero, E., Morales, M.C., et al.Treatment of canine leishmaniasis with marbofloxacin in dogs with renal diseasePLoS One12(10),e0185981(2017)
